VIA
TECH icon

Vident Investment Advisory’s Bio-Techne TECH Stock Holding History

Vident Investment Advisory’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-8,568
Closed -$698K – 942
2023
Q2 		$698K Sell
8,568
-1,047
-11% -$84.2K 0.02% 575
2023
Q1 		$713K Buy
+9,615
New +$741K 0.02% 641
2021
Q3 		– Sell
-3,968
Closed -$447K – 1233
2021
Q2 		$447K Sell
3,968
-2,160
-35% -$227K 0.01% 870
2021
Q1 		$585K Sell
6,128
-840
-12% -$76.6K 0.02% 746
2020
Q4 		$553K Buy
6,968
+372
+6% +$26.9K 0.02% 687
2020
Q3 		$409K Sell
6,596
-2,552
-28% -$166K 0.02% 705
2020
Q2 		$604K Buy
+9,148
New +$548K 0.03% 601
2018
Q3 		– Sell
-85,148
Closed -$3.15M – 999
2018
Q2 		$3.15M Buy
85,148
+45,528
+115% +$1.74M 0.12% 220
2018
Q1 		$1.48M Buy
39,620
+10,680
+37% +$377K 0.06% 341
2017
Q4 		$937K Buy
28,940
+12,720
+78% +$404K 0.04% 386
2017
Q3 		$490K Sell
16,220
-6,412
-28% -$190K 0.03% 499
2017
Q2 		$665K Buy
22,632
+7,656
+51% +$209K 0.06% 329
2017
Q1 		$381K Buy
+14,976
New +$387K 0.04% 344

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vident Investment Advisory's TECH Position: Q3 2023 in Review

Vident Investment Advisory sold out of Bio-Techne (TECH) in Q3 2023, closing a stake of 8,568 shares — an estimated $698K sold.

Vident Investment Advisory first reported a position in TECH in Q1 2017 and held it in 13 quarters. The position peaked at $3.15M in Q2 2018. 530 funds tracked by Wall St. Rank hold TECH as of Q3 2023.

  • Vident Investment Advisory reported no remaining Bio-Techne position as of Q3 2023 after selling out during the quarter.
  • Vident Investment Advisory sold 8,568 Bio-Techne shares in Q3 2023, an estimated $698K.
  • Vident Investment Advisory first reported a position in Bio-Techne in Q1 2017 and held it in 13 quarters.
  • Vident Investment Advisory's Bio-Techne position peaked at $3.15M in Q2 2018.
  • 530 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2023.

Based on Vident Investment Advisory's 13F filing for Q3 2023.